Donald Manuel Rincon Jr, LCSW | |
11059 E Bethany Dr, Suite 200, Aurora, CO 80014-2622 | |
(303) 617-2300 | |
(303) 617-2397 |
Full Name | Donald Manuel Rincon Jr |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 11059 E Bethany Dr, Aurora, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154767895 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 00001447 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Donald Manuel Rincon Jr, LCSW 11059 E Bethany Dr, Suite 200, Aurora, CO 80014-2622 Ph: (303) 617-2300 | Donald Manuel Rincon Jr, LCSW 11059 E Bethany Dr, Suite 200, Aurora, CO 80014-2622 Ph: (303) 617-2300 |
News Archive
Many cancer researchers believe that cutting-edge advances in genomics will pave the way for personalized or "precision" cancer medicine for all patients in the near future. A new study by researchers at Dana-Farber Cancer Institute, however, suggest that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients' tumor samples, while others plan to offer this type of cancer gene testing to most of their patients.
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.
Osmetech, plc today announced that the US Food and Drug Administration (FDA) has cleared the eSensor® Thrombophilia Risk Test (TRT), a multiplexed molecular diagnostic test for four genetic markers associated with thrombosis. The panel includes Factor V Leiden, Factor II Prothrombin, MTHFR 677 and MTHFR 1298 in a single test panel.
The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in JAMA.
› Verified 5 days ago
Megan Noelle Hall, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11059 E Bethany Dr # Dt, Ste 200, Aurora, CO 80014 Phone: 303-617-2300 Fax: 303-617-2397 | |
Cassandra Aguilar, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Mary Alice Parks, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11059 E Bethany Dr, Suite 101, Aurora, CO 80014 Phone: 303-617-2469 Fax: 303-617-2475 | |
Susan Wiberg Garrett, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2101 S. Blackhawk St., Suite 240, Aurora, CO 80014 Phone: 720-449-6764 Fax: 720-532-0219 | |
Mrs. Paula Wood Mayer, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2550 S Parker Rd, Aurora, CO 80014 Phone: 303-636-3442 | |
Meagan Hisscock, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11059 E Bethany Dr, Ste 200, Aurora, CO 80014 Phone: 303-617-2300 Fax: 303-617-2397 | |
Ms. Betsy G Long, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-2982 |